The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.

Johnson & Johnson is advancing Alzheimer’s research through precision medicine, focusing on tau-targeting therapies like ...

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...